Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › argatroban

argatroban

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of argatroban

7 trials tracked of argatroban: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 54 citations.

7Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 3 Other / NA 1
  1. Phase 3 Multi-arm Optimization of Stroke Thrombolysis Completed · 54 cited
  2. Phase 4 Safety of Argatroban Infusion in Conduction Disturbances Completed
  3. Phase 4 Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting Completed
  4. Phase 2 Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI) Completed
  5. Phase 2 Argatroban Stroke Treatment - A Pilot Safety Study Completed
  6. Phase 2 Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II Completed
Show 1 more trials
  1. N/A Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Argatroban switch stabilized clinical status in a patient with mechanical aortic valve and LVAD after HIT
Cardiology Sys. Review
Argatroban switch stabilized clinical status in a patient with mechanical aortic valve and LVAD after HIT Blood thinner switch stabilizes LVAD patient with rare clotting disorder
This case report describes the management of heparin-induced thrombocytopenia (HIT) in a patient with a mechanical aortic valve and left ven…
A patient with a mechanical heart valve and LVAD developed dangerous clots after heparin. Switching to argatroban stabilized their condition…
Frontiers Jun 11, 2026
Argatroban plus alteplase shows no daytime benefit but nighttime association with better stroke outcomes
Neurology RCT
Argatroban plus alteplase shows no daytime benefit but nighttime association with better stroke outcomes Stroke drug works better at night than in the morning
This post hoc analysis of a phase 3 RCT in 692 patients with acute ischemic stroke found no significant difference in excellent functional o…
Nighttime stroke treatment with argatroban plus alteplase may improve recovery, while daytime use showed no added benefit.
May 2, 2026
Protocol for argatroban plus clopidogrel versus aspirin plus clopidogrel in acute minor ischemic stroke
Neurology RCT
Protocol for argatroban plus clopidogrel versus aspirin plus clopidogrel in acute minor ischemic stroke Study will compare two blood thinner combinations for minor strokes
This is a study protocol for a randomized controlled trial of 464 patients with acute minor ischemic stroke (NIHSS ≤5) within 72 hours.
A new trial will test if adding argatroban to clopidogrel leads to better recovery than aspirin plus clopidogrel for minor stroke patients.
medRxiv Apr 4, 2026